Banner Beats Biogen On Tecfidera Technicality

Hybrid 505(b)(2) Product Holds Tentative US Approval

 
• By Dean Rudge
Gavels
A US Court Appeals has ruled in favor of Banner Life Sciences • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin